These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37664046)

  • 1. A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Peng W; Wan L; Wang S; Zou S; Zhao X; Zhang H
    Front Oncol; 2023; 13():1234619. PubMed ID: 37664046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-Based Radiomic Models Outperform Radiologists in Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Wen L; Liu J; Hu P; Bi F; Liu S; Jian L; Zhu S; Nie S; Cao F; Lu Q; Yu X; Liu K
    Acad Radiol; 2023 Sep; 30 Suppl 1():S176-S184. PubMed ID: 36739228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of pathological response and lymph node metastasis after neoadjuvant therapy in rectal cancer through tumor and mesorectal MRI radiomic features.
    Qin S; Liu K; Chen Y; Zhou Y; Zhao W; Yan R; Xin P; Zhu Y; Wang H; Lang N
    Sci Rep; 2024 Sep; 14(1):21927. PubMed ID: 39304726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
    Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
    Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI-based radiomic model for predicting lymph node metastasis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wei Q; Chen L; Hou X; Lin Y; Xie R; Yu X; Zhang H; Wen Z; Wu Y; Liu X; Chen W
    Insights Imaging; 2024 Jun; 15(1):163. PubMed ID: 38922456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric magnetic resonance imaging (MRI)-based radiomics model explained by the Shapley Additive exPlanations (SHAP) method for predicting complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicenter retrospective study.
    Wang Y; Zhang L; Jiang Y; Cheng X; He W; Yu H; Li X; Yang J; Yao G; Lu Z; Zhang Y; Yan S; Zhao F
    Quant Imaging Med Surg; 2024 Jul; 14(7):4617-4634. PubMed ID: 39022292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics of locally advanced rectal cancer: machine learning-based prediction of response to neoadjuvant chemoradiotherapy using pre-treatment sagittal T2-weighted MRI.
    Yardimci AH; Kocak B; Sel I; Bulut H; Bektas CT; Cin M; Dursun N; Bektas H; Mermut O; Yardimci VH; Kilickesmez O
    Jpn J Radiol; 2023 Jan; 41(1):71-82. PubMed ID: 35962933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
    Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MRI-based Radiomics approaches on predicting response to neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer.
    Cheng Y; Luo Y; Hu Y; Zhang Z; Wang X; Yu Q; Liu G; Cui E; Yu T; Jiang X
    Abdom Radiol (NY); 2021 Nov; 46(11):5072-5085. PubMed ID: 34302510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics.
    Wan L; Sun Z; Peng W; Wang S; Li J; Zhao Q; Wang S; Ouyang H; Zhao X; Zou S; Zhang H
    J Magn Reson Imaging; 2022 Oct; 56(4):1130-1142. PubMed ID: 35142001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of locally advanced rectal cancer response to neoadjuvant chemoradiation therapy using volumetric multiparametric MRI-based radiomics.
    El Homsi M; Bane O; Fauveau V; Hectors S; Vietti Violi N; Sylla P; Ko HB; Cuevas J; Carbonell G; Nehlsen A; Vanguri R; Viswanath S; Jambawalikar S; Shaish H; Taouli B
    Abdom Radiol (NY); 2024 Mar; 49(3):791-800. PubMed ID: 38150143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
    Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
    [No Abstract]   [Full Text] [Related]  

  • 14. MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Yi X; Pei Q; Zhang Y; Zhu H; Wang Z; Chen C; Li Q; Long X; Tan F; Zhou Z; Liu W; Li C; Zhou Y; Song X; Li Y; Liao W; Li X; Sun L; Pei H; Zee C; Chen BT
    Front Oncol; 2019; 9():552. PubMed ID: 31293979
    [No Abstract]   [Full Text] [Related]  

  • 15. External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study.
    Wei Q; Chen Z; Tang Y; Chen W; Zhong L; Mao L; Hu S; Wu Y; Deng K; Yang W; Liu X
    Eur Radiol; 2023 Mar; 33(3):1906-1917. PubMed ID: 36355199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Joint Prediction Model Based on Both the Radiomics and Clinical Factors for Predicting the Tumor Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer.
    Liu Y; Zhang FJ; Zhao XX; Yang Y; Liang CY; Feng LL; Wan XB; Ding Y; Zhang YW
    Cancer Manag Res; 2021; 13():3235-3246. PubMed ID: 33880066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
    Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
    Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
    Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
    Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
    Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
    [No Abstract]   [Full Text] [Related]  

  • 20. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.